Importantly, m6A modification modulators, including methyltransferases, demethylases, and binding proteins, are involved in the initiation and evolution of human cancer by numerous mechanisms, such as regulating mRNA splicing and stability, controlling nuclear export, affecting translation efficiency, and mediating microRNA processing [41–45]. This evidence concerns the gene MBD2 and cancer.